Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura

Current Medical Research and Opinion

Volumn 13, Issue 9, 1997, Pages 517-527

  Pacetti, P ^c   Garau, D ^a   Caramatti, C ^a   Mangoni, L ^a   Zamboni, V ^b   Canova, N ^b   Rizzoli, V ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Alfa Wassermann SpA   (Italy)

^c NONE

Author keywords

Adverse effects; Idiopathic thrombocytopenic purpura; Intravenous immunogammaglobulin

Indexed keywords

HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; DYSPNEA; EPISTAXIS; ERYTHEMA; FEMALE; HEADACHE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRURITUS; RASH; THROMBOCYTE COUNT;

EID: 0030915480     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007999709113325     Document Type: Article

References (46)

1. Abdou, M. I., Wall, H., Lindsey, H. B., Hasley, J. F., and Susuki, T., (1981). Network theory in autoimmunity: in vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J. Clin. Invest., 67, 1297-1304.
2. Anderson, C. L., (1989). Human IgG Fc receptors. Clin. Immunol. Immunopathol., 53 (2, Pt 2), S63-S71.
3. Berchtold, P., (1991). New aspects of mechanism of action in chronic ITP. In: Imbach, P. (Ed.), Immunotherapy with Intravenous Immunoglobulins. Academic Press, London, pp. 245-252.
4. Berchtold, P., Dale, G. L., Tani, P., and McMillan, R., (1989). Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIA by antiidiotypic antibodies in intravenous gammaglobulin. Blood, 74 (7), 2414-2417.
5. Berchtold, P., and McMillan, R., (1989). Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood, 74 (7), 2309-2317.
6. Bierling, P., Divine, M., Farcet, J. P., Wallet, P., and Duedari, N., (1987). Persistent remission of adult thrombocytopenic purpura after treatment with high-dose intravenous immunoglobulin. Am. J. Hematol., 25, 271-275.
7. Bijsterbosch, M. K., and Klaus, G. G., (1985). Cross-linking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors. J. Expl Med., 162 (6), 1825-1836.
8. Bussel, J. B., Fitzerald-Pedersen, J., and Feldman, C., (1990). Alternation of two doses of intravenous gammaglobulin in the maintenance treatment of patients with immune thrombocytopenic purpura. Am. J. Hematol., 33, 184-188.
9. Bussel, J. B., Kimberly, R. P., Inman, R. D., Schulman, I., Cunningham-Rundles, C., Cheung, N., Smithwick, E. M., O'Malley, J., Barandun, S., and Hilgartner, M. W., (1983). Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood, 62 (2), 480-486.
10. Bussell, J. B., Pham, L. C., Aledort, L., and Nachman, R., (1988). Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood, 72 (1), 121-127.
11. Bussel, J. B., and Pham, L. C., (1987). Intravenous treatment with gammaglobulin in adults with chronic refractory immune thrombocytopenic purpura: review of the literature. Vox. Sang., 52, 206-211.
12. Cantu, T. G., Hoehn-Saric, E. W., Burgess, K. M., Racusen, L., and Scheel, P. J., (1995). Acute renal failure associated with immunoglobulin therapy. Am. J. Kidney Dis., 25 (2), 228-234.
13. Clarkson, S. B., Bussel, J., Kimberly, R., Valinsky, J., Nachman, R. L., and Unkeless, J. C., (1986). Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma receptor antibody. N. Engl. J. Med., 314, 1236-1239.
14. Collins, P. W., and Newland, A. C., (1992). Treatment modalities of autoimmune blood disorders. Semin. Hematol., 29, 64-74.
15. Cortelazzo, S., Finazzi, G., Buelli, M., Molteni, A., Viero, P., and Barbui, T., (1991). High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood, 77 (1), 31-33.
16. Dammacco, F., Iodice, G., and Campobasso, N., (1986). Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM-induced antibody synthesis in vitro. Brit. J. Haematol., 62, 125-135.
17. Dietrich, G., and Kazatchkine, M. D., (1990). Normal immunoglobulin G for therapeutic use contains antiidiotypic specificities against an immunodominant, crossreactive idiotype of human antibodies. J. Clin. Invest., 85, 620-625.
18. Dwyer, J. M., (1992). Manipulating the immune system with immune globulin. N. Engl. J. Med., 326 (2), 107-116.
19. Fehr, J., Hofmann, V., and Kappeler, U., (1982). Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N. Engl. J. Med., 306, 1254-1258.
20. Fong, S., Chen, P. P., Gilbertson, T. A., Weber, J. R., Fox, R. I., and Carson D. A., (1986). Expression of three crossreactive idiotypes on rheumatoid factor autoantibodies from patients with autoimmune diseases and seropositive adults. J. Immunol., 137, 122-128.
21. Fujisawa, K., Tani, P., Piro, L., and McMillan, R., (1993). The effect of therapy on platelet-associated autoantibody in chronic immune thrombocytopenic purpura. Blood, 81 (11), 2872-2877.
22. Godeau, B., Lesage, S., Divine, M., Wirquin, V., Farcet, J.P., and Bierling, P., (1993). Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. Blood, 82 (5), 1415-1421.
23. Gutteridge, C. N., Veys, P., and Newland, A. C., (1988) Safety of intravenous immunoglobulin for treatment of autoimmune thrombocytopenia. Acta Haematol., 79 (2), 88-90.
24. Imbach, P., Barandun, S., Cottier, H., Gugler, E., Hassig, A., Morell, A., Wagner, A., and Heiniger, H., (1990). Immunomodulation by intravenous immunoglobulin. Am. J. Ped. Haematol./Oncol., 12 (2), 134-140.
25. Imbach, P., Berchtold, W., Hirt, A., Mueller-Eckhardt, C., Rossi, E., Wagner, H. P., Gaedickes, G., Joller, P., Muller, B., and Barandun, S., (1985). Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet, ii, 464-68.
26. Imbach, P., D'Apuzzo, V., Hirt, A., Rossi, E., Vest, M., Barandun, S., Baumgartner, C., Morell, A., Schoni, M., and Wagner, H. P., (1981). High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, i, 1228-1231.
27. Imholz, B., Imbach, P., Baumgartner, C., Berchtold, W., Gaedicke, G., Gugler, E., Hirt, A., Hitzig, W., Mueller-Eckhardt, C., and Wagner, H. P., (1988). Intravenous immunoglobulin for previously treated acute or for chronic idiopathic thrombocytopenic purpura in childhood: a prospective multicenter study. Blut, 56, 63-68.
28. Kurlander, R. J., and Rosse, W. F., (1986). Efficacy of a 2 day schedule for administering intravenous immunoglobulin (IGIV) in treating adults with ITP. Blood, 68 (Suppl 1), Abstract 112a.
29. Lang, J. M., Faradji, A., Giron, C., Bergerat, J. P., and Oberling, F., (1984). High dose Intravenous IgG for chronic idiopathic thrombocytopenic purpura in adults. Blut, 49, 95-99.
30. Macey, M. G., and Newland, A. C., (1990). CD4 and CD8 subpopulation changes during high dose intravenous immunoglobulin treatment. Br. J. Haematol., 76 (4), 513-520.
31. McMillan, R., (1981). Chronic idiopathic thrombocytopenic purpura. N. Engl. J. Med., 304: 1135-1147.
32. Mueller-Eckhardt, C., Kayser, W., Mersch-Baumert, K., Mueller-Eckhardt, G., Breidenbach, M., Kugel, H. G., and Graubner M., (1980). The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders. Br. J. Haematol., 46, 123-131.
33. Newland, A. C., Treleaven, J. G., Minchinton, R. M., and Waters, A. H., (1983). High dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet, 1, 84-87.
34. Pogliani, E. M., Arienti, F., and Corneo, G., (1989). Intravenous infusions of gammaglobulin in adults with chronic refractory immune thrombocytopenic purpura. (Letter) Blood, 74 (2), 886.
35. Poullin, P., Moulin, B., Ollier, J., Benaicha, M., Olmer, M., and Gabriel, B., (1995). Complications renales des immunoglobulines intraveineuses. Rôle des facteurs hemodynamiques renaux. Presse Med., 24 (9), 441-444.
36. Rault, R., Piraino, B., Johnston, J. R., and Oral, A., (1991). Pulmonary and renal toxicity of intravenous immunoglobulin. Clin. Nephrol., 36 (2), 83-86.
37. Rodeghiero, F., Schiavotto, C., Castaman, G., Vespignani, M., Ruggeri, M., and Dini, E., (1992). A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins. Haematologica, 77, 248-252.
38. Rossi, F., and Kazatchkine, M. D., (1989). Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J. Immunol., 143, 4104-4109.
39. Rossi, F., Sultan Y., and Kazatchkine, M. D., (1988). Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic poly-specific normal immunoglobulins. Clin. Expl Immunol., 74, 311-316.
40. Rossi Ferrini, P., (1988). In: Rossi Ferrini, P. (Ed.), Impiego clinico delle immunoglobuline endovena: presente e futuro. Abstract Book, Florence, 19-20 November.
41. Schiavotto, C., Ruggeri, M., and Rodeghiero, F., (1993). Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica, 78 (6, Suppl 2), 35-40.
42. Schmidt, R. E., Budde, U., Schafer, G., and Stroehmann, I., (1981). High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura. (Letter) Lancet, 2, 475-476.
43. Sultan, Y., Maisonneuve, P., Kazatchkine, M. D., and Nydegger, U. E., (1984). Antiidiotypic suppression of antibodies to factor VIII by high dose intravenous gammaglobulin. Lancet, ii, October 6, 765-768.
44. Tsubakio, T., Kurata, Y., Katagiri, S., Kanakura, Y., Tamaki, T., Kuyama, J., Kanayama, Y., Yonezawa, T., and Tarui, S., (1983). Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gammaglobulin therapy in patients with idiopathic thrombocytopenic purpura. Clin. Expl Immunol., 53, 697-702.
45. Vainchenker, W., Tabilio, A., Vinci, G., Henri, A., Breton-Gorius, J., Brouet, J. L., and Clauvel, J. P., (1983). Number of small megakaryocyte precursors and megakaryocyte progenitor cells in autoimmune thrombocytopenic purpura after and before treatment. Expl Haematol., 11 (Suppl. 14), Abstract, 103.
46. Winward, D. B., and Brophy, M. T., (1995). Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report. Pharmacother., 15 (6), 765-772.